TCL Archive Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals September 7, 1979
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions March 16, 1979
TCL Archive Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown May 5, 1978
